Applied Molecular Transport Inc. (NASDAQ:AMTI) finished Friday with an addition of $0.06 to close at $0.42, an upside of 17.85 percent. An average of 1,703,700 shares of common stock have been traded in the last five days. There was a fall of -$0.6100 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 565,385 shares traded, while the 50-day average volume stands at 325,424.
AMTI stock has decreased by -60.00% in the last month. The company shares reached their 1-month lowest point of $0.3300 on 12/30/22. With the stock rallying to its 52-week high on 01/03/22, shares of the company touched a low of $0.33 and a high of $14.48 in 52 weeks. It has reached a new high 1 time so far this year and lost -97.00% or -$13.5600 in price. In spite of this, the price is down -97.10% from the 52-week high.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
AMTI stock investors should be aware that Applied Molecular Transport Inc. (AMTI) stock had its last reported insider trading activity 29 days ago on Dec 02. In this transaction, the insider spent $3,663. CFO, Hants Brandon, disposed of 1,959 shares at a price of $1.05 on Dec 02. The insider now owns more than $2,057 worth of shares. Prior to that, President & COO Cross Shawn went on to Sale 3,893 shares at $1.05 each on Dec 02. An amount of $4,088 was transacted.
The quick ratio of Applied Molecular Transport Inc. for the three months ended June 29 was 5.70, and the current ratio was 5.70, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.01 for the quarter ending June 29.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Applied Molecular Transport Inc.’s return on assets was -80.20%.
The company posted a net income of -$25.21 million in the quarter, while revenues of -$35.95 million were shrunk -3.09%. The analyst consensus anticipated Applied Molecular Transport Inc.’s latest quarter earnings to come in at -$0.78 per share, but it turned out to be -$0.93, a -19.20% surprise. Shareholders own equity worth $38.94 million.
From a technical analysis perspective, let’s take a brief look at Applied Molecular Transport Inc. (AMTI) price momentum. RSI 9-day as of the close on 30 December was 24.72%, suggesting the stock is oversold, with historical volatility in this time frame at 434.31%.
As of today, AMTI’s price is $0.3860 -59.22% or -$0.6100 from its 5-day moving average. AMTI is currently trading -58.00% lower than its 20-day SMA and -76.92% lower than its 100-day SMA. However, the stock’s current price level is -65.00% below the SMA50 and -93.88% below the SMA200.
The stochastic %K and %D were 4.08% and 2.62%, respectively, and the average true range (ATR) was 0.1364. With the 14-day stochastic at 9.18% and the average true range at 0.1409, the RSI (14) stands at 29.18%. The stock has reached -0.3039 on the 9-day MACD Oscillator while the 14-day reading was at -0.4904.
JMP Securities launched coverage on Applied Molecular Transport Inc. (NASDAQ: AMTI) in its analyst report released on March 17, 2021. The firm assigned the stock a Mkt outperform rating. The consensus rating for Applied Molecular Transport Inc. (AMTI) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell AMTI, while 3 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 2 others rate it as a “buy”.
What is AMTI’s price target for the next 12 months?
Analysts predict a range of price targets between $0.80 and $5.00, with a median target of $2.50. Taking a look at these predictions, the average price target given by analysts for Applied Molecular Transport Inc. (AMTI) stock is $2.70.